BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1359849)

  • 1. CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall.
    Perkins PL; Ross CW; Schnitzer B
    Arch Pathol Lab Med; 1992 Nov; 116(11):1192-6. PubMed ID: 1359849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
    Tsurumi H; Takahashi T; Moriwaki H; Muto Y
    Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
    Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
    Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS; Singleton TP; Weiss SW
    Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine needle aspiration biopsy of Ki-1-positive large-cell "anaplastic" lymphoma.
    Yazdi HM; Burns BF
    Acta Cytol; 1991; 35(3):306-10. PubMed ID: 1645922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
    Siebert JD; McClure SP; Banks PM; Gulley ML
    Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunohistochemistry of Hodgkin's disease.
    Said JW
    Semin Diagn Pathol; 1992 Nov; 9(4):265-71. PubMed ID: 1362283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.
    Carbone A; Gloghini A; Volpe R
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):527-32. PubMed ID: 1376944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A; Gloghini A; Volpe R
    Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-1 positive (anaplastic, large cell) lymphoma (case reports and review).
    Kopper L; Rényi I; Pápay J; Kardos G; Bánkfalvi A; Bartók M; Rákóczy G
    Acta Paediatr Hung; 1992; 32(3):257-67. PubMed ID: 1335739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of phenotyping by Ber-H2, Leu-M1, EMA in Hodgkin's disease.
    de Mascarel I; Trojani M; Eghbali H; Coindre JM; Bonichon F
    Arch Pathol Lab Med; 1990 Sep; 114(9):953-5. PubMed ID: 1975165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distinction of Hodgkin's disease from anaplastic large cell lymphoma.
    Frizzera G
    Semin Diagn Pathol; 1992 Nov; 9(4):291-6. PubMed ID: 1480851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation.
    Novoa-Takara L; Dincer A; Kampalath B; Van Tuinen P; Hariharan S; Chang C
    Histopathology; 2005 Sep; 47(3):333-4. PubMed ID: 16115242
    [No Abstract]   [Full Text] [Related]  

  • 19. Hodgkin's disease and an extranodal marginal zone B-cell lymphoma in the small intestine: an unusual composite lymphoma.
    Aguilera NS; Howard LN; Brissette MD; Abbondanzo SL
    Mod Pathol; 1996 Oct; 9(10):1020-6. PubMed ID: 8902841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-cell anaplastic (Ki-1-positive) lymphoma complicated by disseminated intravascular coagulation.
    Arber D; Bilbao J; Bassion S
    Arch Pathol Lab Med; 1991 Feb; 115(2):188-92. PubMed ID: 1847037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.